New Innovations Pharma Separator Lines for Biopharmaceutical Separation Processes
Gea’s new pharmaceutical separator lines ‘aseptic’ and ‘pure’ are ushering in a new era for biopharmaceutical separation processes. The separator lines are used in all pharmaceutical and biotechnological downstream processes.
The company’s aseptic separator line offers customers with highly hygienic processes gentle processing of, for example, human and veterinary vaccines, monoclonal antibodies (mAb), e-coli, insulin, starter cultures and probiotic products. The ‘pure’ line is used in applications with varying hygienic requirements such as nutritional supplements, therapeutic proteins, pharmaceutical extractions, and extracellular and intracellular enzyme recovery.
The new pharmaceutical separator lines were developed to the highest Gea standards at the German Gea Westfalia Separator plant in Oelde, where they are built and tested. The ‘aseptic’ line stands for the highest hygienic pharmaceutical requirements.
According to the company, the ‘pure’ line provides maximum variability and is perfectly tailored to the diverse process requirements of the biopharmaceutical industry. All functions for pharmaceutical cleanliness requirements such as an automatic CIP (Cleaning-in-Place), SIP (Steam Sterilization in Place), simple validation and a high-end qualification package are included. In addition, with the help of the cGMP validation process (Current Good Manufacturing Practice, cGMP), the pharma separators support the firm’s customers in their quality standard reviews.